<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 25, 2000
----------------
HCA - THE HEALTHCARE COMPANY
(Exact Name of Company as Specified in Its Charter)
DELAWARE 001-11239 75-2497104
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
ONE PARK PLAZA
NASHVILLE, TENNESSEE 37203
(Address and Zip Code of Principal Executive Offices)
(615) 344-9551
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 5. OTHER EVENTS.
In connection with the issuance and sale, pursuant to the Securities
Act of 1933, as amended, of an aggregate of L.150,000,000 principal amount of
the Registrant's 8.75% Notes due 2010, the Registrant files herewith those
Exhibits listed in Item 7(c) below.
ITEM 7(c). EXHIBITS.
The following Exhibits are furnished in accordance with Item 601 of
Regulation S-K:
Exhibit 1.1 Underwriting Agreement Standard Provisions (Debt
Securities) dated October 25, 2000.
Exhibit 1.2 Underwriting Agreement (Terms) dated October 25, 2000,
by and among HCA - The Healthcare Company, Deutsche Bank
AG London, Morgan Stanley & Co. Incorporated and Salomon
Brothers International Limited.
Exhibit 4.1 8.75% Note due 2010 in the principal amount of
L.150,000,000.
Exhibit 10.1 Agency Agreement dated as of October 25, 2000, by and
among HCA - The Healthcare Company, Bank One, NA, London
Branch and Credit Agricole Indosuez Luxembourg S.A.
-2-
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HCA - THE HEALTHCARE COMPANY
/s/ John M. Franck II
--------------------------------------------
John M. Franck II
Vice President and Corporate Secretary
November 6, 2000
